You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly Diagnosed

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • iNUDGE
  • Cherry Hill, New Jersey
  • +5 more
May 9, 2023

Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)

Recruiting
  • Glioblastoma
  • Newly Diagnosed Glioblastoma
  • Optune
  • +3 more
  • Stanford, California
    Stanford University
Aug 1, 2022

Virologic Response in Participants Newly Diagnosed With HIV-1

Completed
  • HIV
  • Antiretroviral Therapy
  • Lisboa, Portugal
    Chlo - Hosp. Egas Moniz
Jan 17, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Large B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • BCMA CAR-T cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jan 31, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

Newly Diagnosed Mantle Cell Lymphoma Trial in Zhengzhou (Rituximab)

Recruiting
  • Newly Diagnosed Mantle Cell Lymphoma
  • Zhengzhou, Henan, China
    Department of Oncology, The First Affiliated Hospital of Zhengzh
Aug 17, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Celiac Disease, Gluten Sensitivity, Gluten Allergy Trial (gluten-free oats)

Not yet recruiting
  • Celiac Disease
  • +3 more
  • gluten-free oats
  • (no location specified)
Mar 27, 2023

Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 2, 2023

Glioblastoma Trial in Boston (ITI-1001)

Not yet recruiting
  • Glioblastoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 13, 2023

Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt

Not yet recruiting
  • Advanced Ovarian Cancer
  • None (Observational Study)
  • (no location specified)
Mar 8, 2023

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

Chronic GVHD Trial in Bethesda, Saint Louis (Ibrutinib)

Recruiting
  • Chronic GVHD
  • Bethesda, Maryland
  • +1 more
Jan 26, 2023

Daratumumab in Combination With Bortezomib, Thalidomide, and

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
  • (no location specified)
Sep 27, 2022

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

Recruiting
  • Insulin Pump，Continuous Glucose Monitoring Technology
  • Insulin Glargine
  • +3 more
  • Guandong, China
    刘烈华
Nov 7, 2023

Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)

Recruiting
  • Glioblastoma
  • Concurrent CRT Period
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Johns Hopkins Hospital
Mar 2, 2023

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Metastatic Prostatic Adenocarcinoma Trial in Charleston (Docetaxel, Degarelix)

Active, not recruiting
  • Metastatic Prostatic Adenocarcinoma
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 30, 2023

Oropharyngeal Squamous Cell Carcinoma (SCC) Trial run by the National Cancer Institute (NCI) (PRGN-2009, Pembrolizumab)

Not yet recruiting
  • Oropharyngeal Squamous Cell Carcinoma (SCC)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 22, 2023

Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)

Recruiting
  • Multiple Myeloma
  • Palliative Care
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

Not yet recruiting
  • Leukemia, Juvenile Myelomonocytic
  • +4 more
  • (no location specified)
May 4, 2023

Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 13, 2022